Henry Schein Inc. (HSIC) exhibits 31.1% gross margins and 11.2% return on invested capital within Health Care (Medical Specialities), balanced against a 9.5x enterprise multiple and 6.5% implied options volatility.
Sustained 31.1% gross profitability converts into 5.0% operating margin and 11.2% ROIC, outpacing sector cost of capital.
ROIC: 11.2% // GM: 31.1%YoY revenue trajectory of +4.0% paired with 1.23% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +4.0% // FCF YLD: 1.23%Altman Z-Score of 2.81 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.81 // F-SCORE: 7/9Trading at 23.0x trailing P/E (21.4x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 23.0x // EV/EBITDA: 9.5xOptions market prices a ±6.5% implied move with a 0.83 put/call ratio around $85.00 max pain.
IMPL MOVE: ±6.5% // P/C: 0.83Elevated industry capital intensity and customer concentration in Medical Specialities require continuous execution to defend 3.2% net margins.
NET MARGIN: 3.2% // D/E: 0.83x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for HSIC & activate live FRED threshold breach alerts.